GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $268,000 | -8.5% | 6,957 | +2.3% | 0.07% | -11.5% |
| Q3 2016 | $293,000 | +2.8% | 6,803 | +3.4% | 0.08% | -34.5% |
| Q2 2016 | $285,000 | +26.7% | 6,578 | +18.5% | 0.12% | +24.0% |
| Q1 2016 | $225,000 | +0.4% | 5,553 | -0.1% | 0.10% | -2.0% |
| Q4 2015 | $224,000 | +1.4% | 5,556 | -3.3% | 0.10% | -2.0% |
| Q3 2015 | $221,000 | -17.8% | 5,747 | -1.5% | 0.10% | -9.9% |
| Q2 2015 | $269,000 | 0.0% | 5,833 | 0.0% | 0.11% | 0.0% |
| Q1 2015 | $269,000 | +8.0% | 5,833 | +0.1% | 0.11% | -0.9% |
| Q4 2014 | $249,000 | +5.1% | 5,827 | +13.2% | 0.11% | -2.6% |
| Q3 2014 | $237,000 | +1.7% | 5,147 | +18.4% | 0.12% | +10.6% |
| Q2 2014 | $233,000 | +2.6% | 4,348 | +2.5% | 0.10% | -1.9% |
| Q1 2014 | $227,000 | +10.7% | 4,243 | +10.5% | 0.11% | +14.0% |
| Q4 2013 | $205,000 | – | 3,840 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |